Jim Cramer Says PepsiCo (PEP) ‘In The Crosshairs’ of Weight Loss Drugs
Stocks to Buy or Sell. In this article, we are going to take a look at where PepsiCo, Inc. (NASDAQ:PEP) stands against other ...
Jim Cramer Says J. M. Smucker (SJM) Can’t ‘Overrun Sentiment’ Amid Weight Loss Drugs Threat
Jim Cramer in a latest program mentioned an analyst downgrade on The J. M. Smucker Company (NYSE:SJM) and reiterated that he ...
News 12 Networks17h
The pros and cons of injectable weight loss medications
Doctors say that for many patients, these medications help them get control of their obesity and other weight-related medical issues, along with improving their blood sugar and heart health. However, ...
Futurism17h
Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...